Related Experiment Video
Updated: Jan 13, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Chronic Infections as Catalysts for Melanoma Aggressiveness: Insights into Tumour Microenvironment Modulation
Layza Sá Rocha1, Ana Cristina Jacobowski1, Eduarda Thiburcio Do Nascimento Reis1
1Laboratory of Protein Purification and their Biological Functions, Federal University of Mato Grosso do Sul, 79070-900 Campo Grande-MS, Brazil.
Background:
Cutaneous melanoma is a highly aggressive skin cancer known for its metastatic potential and resistance to conventional therapies. While genetic and environmental factors are well-recognized in melanoma progression, the impact of chronic microbial infections is not fully understood. Recent studies suggest microbial pathogens interact with the tumour microenvironment, facilitating immune evasion, epithelial-mesenchymal transition (EMT), and therapy resistance. This study aims to explore how chronic infections contribute to melanoma aggressiveness and assess the potential of antimicrobial peptides (AMPs) as a new therapeutic approach.
Methods:
A systematic review was conducted according to PRISMA 2020 guidelines, utilising academic databases (PubMed, Scopus, Web of Science, and Google Scholar) from 2020 to 2025. Peer-reviewed studies were screened to identify microbial species linked to melanoma, antimicrobial resistance (AMR), and the effectiveness of AMPs. Data on cytokines, immune pathways, and bioinformatics approaches to AMP design were synthesized.
Results:
The review revealed that pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and Candida tropicalis exacerbate melanoma progression by inducing chronic inflammation, promoting pro-inflammatory cytokines (IL-6, TNF-α), and enhancing EMT, which aids tumour invasion and metastasis. AMR complicates treatment, particularly in immunocompromised patients. AMPs were identified as promising agents due to their dual action: antimicrobial activity and immunomodulation. Advances in bioinformatics and AI have facilitated the rational design of AMPs with improved specificity and reduced cytotoxicity, suggesting potential synergy with immune checkpoint inhibitors and targeted therapies.
Conclusion:
Chronic microbial infections significantly influence melanoma aggressiveness and treatment resistance. AMPs offer a promising, multifunctional therapeutic approach, addressing infection control and tumour microenvironment modulation. Combining AMPs with current immunotherapies may enhance melanoma management. Further research and clinical trials are needed to validate and optimise AMP-based treatments for personalised care.
Insights
Chronic microbial infections worsen melanoma aggressiveness and resistance to treatment. Antimicrobial peptides (AMPs) show promise for controlling infection and improving melanoma therapy by modulating the tumor microenvironment.
Area of Science:
- Oncology
- Microbiology
- Immunology
Background:
- Cutaneous melanoma is an aggressive skin cancer with high metastatic potential.
- Chronic microbial infections are increasingly recognized to influence melanoma progression and therapy resistance.
- Pathogen interactions within the tumor microenvironment can promote immune evasion and epithelial-mesenchymal transition (EMT).
Purpose of the Study:
- To investigate the role of chronic infections in melanoma aggressiveness.
- To evaluate antimicrobial peptides (AMPs) as a potential therapeutic strategy for melanoma.
Main Methods:
- A systematic review of peer-reviewed studies from 2020-2025 was conducted.
- Databases searched included PubMed, Scopus, Web of Science, and Google Scholar.
- Data synthesis focused on microbial species, antimicrobial resistance (AMR), AMP effectiveness, cytokines, immune pathways, and bioinformatics.
Main Results:
- Specific pathogens (e.g., S. aureus, P. aeruginosa, C. tropicalis) exacerbate melanoma via inflammation and EMT.
- Antimicrobial resistance (AMR) complicates treatment, especially in immunocompromised individuals.
- Antimicrobial peptides (AMPs) demonstrate dual antimicrobial and immunomodulatory effects, with AI-driven design enhancing specificity and safety.
Conclusions:
- Chronic microbial infections significantly impact melanoma aggressiveness and treatment resistance.
- Antimicrobial peptides (AMPs) present a promising multifunctional approach for melanoma management.
- Combining AMPs with immunotherapy may improve patient outcomes, warranting further clinical investigation.
Related Concept Videos
The Tumor Microenvironment
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...

